Key facts
- Irisbond’s last known valuation is $6.7M (Aug 2018).
- It has raised $9.2M; the latest was Later Stage VC ($4.8M) in Mar 2025.
- Notable investors include BIND 4.0, Business Factory Auto, Everis Group, Fitalent, Geroa Pentsioak — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Irisbond
- ·The full record, as it builds
Funding rounds
No funding rounds for Irisbond are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Irisbond
Developer of a system-based eye-tracker designed for humans to communicate based on precision eye-tracking technology. The company creates an infrared-based eye-tracking device that is used to control the eye movements of affected patients with speech impairments and mobility limitations, enabling individuals with special needs to regain the ability to communicate, improve accessibility, and facilitate interaction.
- Sector
- Healthcare
- HQ
- Donostia San-Sebastián, Spain
- Founded
- 2013
- Employees
- 45
- Website
- irisbond.com/
- Ownership
- Privately Held (backing)
Irisbond doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Irisbond shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Irisbond in its N-PORT filings yet. We sweep new filings monthly.